Fundraising Fox
seqWell
Beverly, US · Founded 2014 · Delaware corporation · 3 known investors
Find your way into seqWell
Sign up to see every warm intro you have to seqWell
- Paths you didn't know you had: your email and LinkedIn already hold routes to the seqWell team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
seqWell develops reagents and technologies for next-generation sequencing library preparation, serving academic and institutional research clients. The company's proprietary plexWell platform enables researchers to streamline NGS workflows.
Founders & leadership
DC
Daniel CalvoExecutive
J
Joe
J
Jack
JM
Joseph MellorNamed on SEC filing
JM
Joseph Mellor, Ph.D.Named on SEC filing
Board
AL
Amy LiaoBoard director
CS
AP
Anup ParikhBoard director
PM
Paul McEwanBoard director
Investors · 3
BroadOak Capital PartnersreportedBethesda
How we know: funding news · globenewswire.com · Not right? Tell us
Research Corporation TechnologiesreportedTucson
How we know: funding news · globenewswire.com · Not right? Tell us
Also in the syndicate · 1
Codexislead
Reported raises · per SEC filings
Form D private placements$23.5M disclosed across 9 rounds · 2016–2026
▶$960.1KraisedSep 2026 · 10 investors · Other TechnologyRule 506(b)
▶$960.1KraisedSep 2026 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel CalvoExecutive Officer, Director
- Joseph C. MellorExecutive Officer, Director
- Thomas H. GrantExecutive Officer
- Michael FinneyDirector
- Paul McEwanDirector
- Chad SouvignierDirector
- Amy LiaoDirector
- Anup ParikhDirector
- Offering amount
- $1M
- Amount sold
- $960.1K
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedFeb 2025 · 11 investors · Other TechnologyRule 506(b)
▶$3.1MraisedFeb 2025 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MellorExecutive Officer, Director
- Chad SouvignierDirector
- Daniel CalvoExecutive Officer, Director
- Paul McEwanDirector
- Amy LiaoDirector
- Michael FinneyDirector
- Thomas GrantExecutive Officer
- Anup ParikhDirector
- Offering amount
- $3.5M
- Amount sold
- $3.1M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.5KraisedJan 2025 · 1 investors · Other TechnologyRule 506(b)
▶$11.5KraisedJan 2025 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas GrantExecutive Officer
- Amy LiaoDirector
- Chad SouvignierDirector
- Joseph MellorExecutive Officer, Director
- Daniel CalvoExecutive Officer, Director
- Anup ParikhDirector
- Michael FinneyDirector
- Paul McEwanDirector
- Offering amount
- $11.5K
- Amount sold
- $11.5K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4KraisedSep 2023 · 14 investors · Other TechnologyRule 506(b)
▶$3.4KraisedSep 2023 · 14 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MellorExecutive Officer, Director
- Amy LiaoDirector
- Paul McEwanDirector
- Dan CalvoExecutive Officer, Director
- Chad SouvignierDirector
- Michael FinneyDirector
- Thomas GrantExecutive Officer
- Offering amount
- $6.5K
- Amount sold
- $3.4K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedSep 2023 · 14 investors · Other TechnologyRule 506(b)
▶$3.4MraisedSep 2023 · 14 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MellorExecutive Officer, Director
- Paul McEwanDirector
- Thomas GrantExecutive Officer
- Michael FinneyDirector
- Amy LiaoDirector
- Dan CalvoExecutive Officer, Director
- Chad SouvignierDirector
- Offering amount
- $6.5M
- Amount sold
- $3.4M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedMar 2022 · 10 investors · Other TechnologyRule 506(b)
▶$7MraisedMar 2022 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MellorExecutive Officer, Director
- Chad SoveignerDirector
- Thomas H. GrantExecutive Officer
- Rob WilsonDirector
- Dan CalvoExecutive Officer, Director
- Paul McEwanDirector
- Michael FinneyDirector
- Offering amount
- $8M
- Amount sold
- $7M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedJan 2020 · 23 investors · Other TechnologyRule 506(b)
▶$7MraisedJan 2020 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael FinneyDirector
- Joseph C. MellorExecutive Officer, Director
- Paul McEwanDirector
- Offering amount
- $9.3M
- Amount sold
- $7M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$700KraisedMay 2017 · 13 investors · BiotechnologyRule 506(b)
▶$700KraisedMay 2017 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jack LeonardExecutive Officer
- Tom GrantExecutive Officer
- William McKenzieDirector
- Joseph Mellor, Ph.D.Executive Officer, Director
- Michael FinneyDirector
- Offering amount
- $800K
- Amount sold
- $700K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
IDbyDNAScalable, high throughput DNA sequencing platforms.
OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
GenewizGENEWIZ provides sequencing, synthesis, and molecular biology services for research, clinical, and therapeutic applications, serving academic institutions, biotech companies, and pharmaceutical organizations.
Companies working in the same space as seqWell.
Frequently asked questions
- What does seqWell do?
- seqWell develops reagents and technologies for next-generation sequencing library preparation, serving academic and institutional research clients. The company's proprietary plexWell platform enables researchers to streamline NGS workflows.
- Who are seqWell's investors?
- seqWell's investors include BroadOak Capital Partners, Research Corporation Technologies.
- How much funding has seqWell raised?
- seqWell has disclosed $23.5M raised across 9 rounds.
- Where is seqWell headquartered?
- seqWell is headquartered in Beverly, US.